Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Investor Wire

AVEO Quote, Trading Chart, AVEO Pharmaceuticals Inc.


home / stock / aveo / aveo quote

$8.26 Last:

1.1% Change Percent:

$8.19 Open:

$8.26 Previous Close:

$8.42 High:

$7.85 Low:

313,658 Volume:

02/26/2021 04:55:19 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-02-268.198.268.427.85313,658
2021-02-258.548.178.738.05316,247
2021-02-248.758.678.878.47292,855
2021-02-238.498.658.87.81538,353
2021-02-228.978.789.58.65581,535
2021-02-199.18.919.218.7500,952
2021-02-188.988.759.138.27844,673
2021-02-178.278.318.378.03223,212
2021-02-168.668.448.73738.15295,415
2021-02-158.258.498.718.09321,760
2021-02-128.258.498.718.09319,997
2021-02-119.088.149.18.08652,729
2021-02-109.18.789.2058.64385,489
2021-02-099.528.939.61258.81579,771
2021-02-089.29.569.79.0369581,813
2021-02-059.119.1159.28.58383,963
2021-02-048.468.959.018.3828426,309
2021-02-038.378.358.56818.23264,763
2021-02-028.138.298.78404,314
2021-02-017.957.968.187.8201269,646
Stock Information

AVEO Pharmaceuticals Inc. Company Name:

AVEO Stock Symbol:

NASDAQ Market:

MENU
AVEO AVEO Quote AVEO Short AVEO News AVEO Articles AVEO Message Board
Get AVEO Alerts

News, Short Squeeze, Breakout and More Instantly...

Stock Investor Wire
RECENT AVEO NEWS
  • AVEO - AVEO Oncology Announces Participation at the 2021 SVB Leerink Global Healthcare Conference

    AVEO Oncology (Nasdaq: AVEO) today announced that Michael Bailey, president and chief executive officer of AVEO, will participate in a fireside chat at the 2021 SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 3:00 p.m. Eastern Time. A live webcast of t...

  • AVEO - AVEO Oncology Announces Presentation of Key Subgroup and Quality of Life Analyses from the Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma

    – Data Presented at the ASCO 2021 GU Cancers Symposium – –Sequencing Data Support Tivozanib is a Differentiated Selective VEGF TKI; Q-TWiST Quality of Life Measure Shows Significant Improvement for Tivozanib over Sorafenib – AVEO Oncology ...

  • AVEO - AVEO Oncology Announces Commitment for an Incremental $10 Million Loan in Addition to Current Tranched, $35 Million Debt Facility with Hercules Capital

    – $20M Tranche Available on Approval of Tivozanib – AVEO Oncology (Nasdaq: AVEO) today announced that it has received a commitment letter for an incremental $10 million loan from Hercules Capital, Inc. (NYSE: HTGC, “Hercules”) and its affiliates, ...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.


Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News